A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants.
Clinical trial NCT02839135 · COMPLETED
Trial details
- NCT number
- NCT02839135
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-13
- Primary completion
- 2016-08-01
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.